World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12614001208695
Date of registration: 17/11/2014
Prospective Registration: No
Primary sponsor: Rehab Farrag Gwada
Public title: Comparison of Bilevel and Continuous Positive Airway Pressure Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema
Scientific title: Efficacy of Noninvasive Bilevel versus Continuous Positive Airway Pressure on blood gases in Acute Cardiogenic Pulmonary Edema: A Single Blinded Randomized Trial
Date of first enrolment: 13/05/2007
Target sample size: 69
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12614001208695.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Phase 3 / Phase 4
Countries of recruitment
Egypt
Contacts
Name: Dr Rehab Farrag Gwada   
Address:  Department of physical therapy, National Heart Institute,9 Omar Tosoon street , Kitkat, Giza, Egypt Postal Code: 12312 Egypt
Telephone: +20 222524015
Email: rehabfarrag40@yahoo.com
Affiliation: 
Name: Dr Rehab Farrag Gwada   
Address:  Department of physical therapy, National Heart Institute,9 Omar Tosoon street , Kitkat, Giza, Egypt Postal Code: 12312 Egypt
Telephone: +20 222524015
Email: rehabfarrag40@yahoo.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria were: severe dyspnea, bilateral rales on auscultation, and typical findings of congestion on chest radiography without evidence of pulmonary aspiration or pneumonia. In addition, respiratory rate of geater than or equal to 30 breaths per minute, hypoxemia (PaO2 less than80mmHg) with a fraction of inspired oxygen (Fio2) of 60% via a Venturi mask, and PaCO2 less than or equal to 45mmHg[ Nouira et.al 2011 and Ferrari et.al 2009].
Exclusion criteria: The patients were excluded from this study if they required a lifesaving or emergency intervention, such as primary percutaneous coronary intervention, or if they had chronic obstructive pulmonary diseases, hemodynamic instability (systolic BP less than or equal to 90mmHg), or life threatening arrthymia, acute myocardial infarction and/ or unstable angina, recent facial trauma, and esophageal/gastric surgery, gastrointestinal bleeding, or pregnant [Ferrari et.al 2007and Bellone et.al 2005].

Age minimum: 50 Years
Age maximum: 65 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Cardiovascular - Other cardiovascular diseases
Respiratory - Other respiratory disorders / diseases
Acute cardiogenic pulmonary edema ;
Acute cardiogenic pulmonary edema
Intervention(s)
both treatment groups(1and 2) received the standard medical treatment in addition to NIV .The NIV were delivered through a full-face mask by a Respironics Synchrony ventilator (Model RTX Inodes, 10 Downage RespiCare, Drager, London). In the CPAP group(group1) a continuous pressure of 10 cmH2O was generated. Patients in Bi-PAP group(group 2) received IPAP (15 cmH2O) and EPAP (5 cmH2O)
. All patients received their assigned treatment for 1 hour. After NIV mask remove the patients continued to receive standardO2 face mask.

Criteria for termination of noninvasive ventilation therapy include inability to tolerate the tightness of the mask or pressure, abundant secretion or met the criteria for intubation according to Brochard et al. 1995. In those who were unable to tolerate the NIV, it was stopped and standard face mask O2 applied.After study period(90 minutes), the patients were transferred to medical ward or admitted to an intensive care unit(ICU) if they require intubation or did not improve.
Primary Outcome(s)
The primary outcome measures were physiological parameters concerning blood gases (PaCO2,PaO2, SaO2, pH, and HCO3).[The primary outcomes collected before entry of the study (T0), immediately after60minutes of noninvasive ventilation application (T60), and after 30 minutes (T90) of noninvasive ventilation discontinuation. ]
vital signs were continuously monitored using ECG monitor (Hewlett Packard M1092-Italy) to detect their changes .[ collected before entry of the study (T0), immediately after 60minutes of noninvasive ventilation application (T60), and after 30 minutes (T90) of noninvasive ventilation discontinuation]
Secondary Outcome(s)
Secondary outcomes were rate of endotracheal intubation[secondary outcome were reported at the time of discharge.]
the rate of death.[at time of discharge]
Secondary ID(s)
Nil
Source(s) of Monetary Support
Secondary Sponsor(s)
Bassem S, Ibrahim.
Basant Hamdy El-Refay
Ethics review
Status: Approved
Approval date:
Contact:
postgraduate ethics committee , faculty physical therapy, Cairo university.
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history